Science

Apr 17, 2025, 09:27

Myeloma Paper of the Day, April 17th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Patients post-ASCT on Len maint with sustained MRD negativity for >6 mos have superior 3-year PFS vs. those without sustained MRD measured by NGF (100% vs. 67.6%; HR 0.06; P<0.007) and NGS (90.5% vs. 72.2%; HR 0.23; P=0.048).”

“Prognostic value of minimal residual disease detected by EuroFlow next-generation flow cytometry and next-generation sequencing in patients with multiple myeloma achieving complete response and receiving lenalidomide maintenance after autotransplant: a prospective comparison study”

Authors: Takeshi Yoroidaka, Hiroyuki Takamatsu, Ryota Urushihara, Mitsuhiro Itagaki, Satoshi Yoshihara, Tadao Ishida, Kenshi Suzuki, Hirokazu Murakami, Brian Durie, Kazuyuki Shimizu et al.

More posts featuring Robert Orlowski.

Brian Durie cancer EuroFlow Hirokazu Murakami Hiroyuki Takamatsu Kazuyuki Shimizu Kenshi Suzuki Mitsuhiro Itagaki multiple myeloma Myeloma Paper of the Day NGF NGS OncoDaily Oncology Robert Orlowski Ryota Urushihara Satoshi Yoshihara Tadao Ishida Takeshi Yoroidaka

Who From Oncology is Featured in TIME100 Health 2025?

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

Does Plastic Cause Cancer? Myths and Facts